Impact of the EML4-ALK fusion variant on the efficacy of lorlatinib in patients (pts) with ALK-positive advanced non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Bauer, T. M.; Martini, J. F.; Besse, B.; Lin, C. C.; Soo, R. A.; Riely, G. J.; Ou, S. H. I.; Toffalorio, F.; Abbattista, A.; Thurm, H.; Camidge, D. R.; Kao, S.; Chiari, R.; Gadgeel, S.; Felip, E.; Shaw, A. T.; Solomon, B. J. |
| Abstract Title: | Impact of the EML4-ALK fusion variant on the efficacy of lorlatinib in patients (pts) with ALK-positive advanced non-small cell lung cancer (NSCLC) |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059302161 |
| DOI: | 10.1158/1538-7445.Am2020-ct025 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT025 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
